Concepedia

Mark S. Forsythe

MS

14

Publications

597

Citations

13

H-Index

1987

Active since

Affiliations

Wilmington University(Current)

DuPont (United States)

Experimental Station

Mark S. Forsythe is an author at Wilmington University specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1987–2001

14

Publications

14

Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.

Shaker A. Mousa, Jeffrey M. Bozarth, Mark S. Forsythe et al. · Circulation · 1994 · 103 citations · Full text

Comparative In Vitro Efficacy of Different Platelet Glycoprotein IIb/IIIa Antagonists on Platelet-Mediated Clot Strength Induced by Tissue Factor With Use of Thromboelastography

Shaker A. Mousa, Sandeep Khurana, Mark S. Forsythe · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 77 citations

Disubstituted Indazoles as Potent Antagonists of the Integrin α<sub>v</sub>β<sub>3</sub>

Douglas G. Batt, Joseph J. Petraitis, Gregory C. Houghton et al. · Journal of Medicinal Chemistry · 1999 · 72 citations · Full text

, , +15

Novel nonpeptide antiplatelet glycoprotein llb/llla receptor antagonist, DMP754

Shaker A. Mousa, Mark S. Forsythe, William Lorelli et al. · Coronary Artery Disease · 1996 · 47 citations

Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrate.

Andrew T. Chiu, J M Bozarth, Mark S. Forsythe et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 45 citations

Rows per page

1–5 of 14